COMMENTS TO THE GUIDELINES
https://doi.org/10.20996/1819-6446-2010-6-3-412-414
Abstract
Comments to the guidelines.
References
1. Poldermans D., Bax J.J., Boersma E., et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). EurHeartJ 2009;30:2769- 812.
2. Eisenberg M.J., Richard P.R., Libersan D., et al. Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents. Circulation 2009;119:1634-42.
3. Rouleau J.L., Warnica W.J., Baillot R., et al. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery. Circulation 2008;117:24-31.
4. Sabatine M.S., Morrow D.A., de Lemos J.A., et al. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur Heart J 2009;30:162-9.
Review
For citations:
Gilyarevsky S.R. COMMENTS TO THE GUIDELINES. Rational Pharmacotherapy in Cardiology. 2010;6(3):412-414. (In Russ.) https://doi.org/10.20996/1819-6446-2010-6-3-412-414
Views:
633
Email this article 